_version_ 1784639723891851264
author Fendler, Annika
Shepherd, Scott T C
Au, Lewis
Wu, Mary
Harvey, Ruth
Schmitt, Andreas M
Tippu, Zayd
Shum, Benjamin
Farag, Sheima
Rogiers, Aljosja
Carlyle, Eleanor
Edmonds, Kim
Del Rosario, Lyra
Lingard, Karla
Mangwende, Mary
Holt, Lucy
Ahmod, Hamid
Korteweg, Justine
Foley, Tara
Barber, Taja
Emslie-Henry, Andrea
Caulfield-Lynch, Niamh
Byrne, Fiona
Deng, Daqi
Kjaer, Svend
Song, Ok-Ryul
Queval, Christophe
Kavanagh, Caitlin
Wall, Emma C
Carr, Edward J
Caidan, Simon
Gavrielides, Mike
MacRae, James I
Kelly, Gavin
Peat, Kema
Kelly, Denise
Murra, Aida
Kelly, Kayleigh
O'Flaherty, Molly
Shea, Robyn L
Gardner, Gail
Murray, Darren
Yousaf, Nadia
Jhanji, Shaman
Tatham, Kate
Cunningham, David
Van As, Nicholas
Young, Kate
Furness, Andrew J S
Pickering, Lisa
Beale, Rupert
Swanton, Charles
Gandhi, Sonia
Gamblin, Steve
Bauer, David L V
Kassiotis, George
Howell, Michael
Nicholson, Emma
Walker, Susanna
Larkin, James
Turajlic, Samra
author_facet Fendler, Annika
Shepherd, Scott T C
Au, Lewis
Wu, Mary
Harvey, Ruth
Schmitt, Andreas M
Tippu, Zayd
Shum, Benjamin
Farag, Sheima
Rogiers, Aljosja
Carlyle, Eleanor
Edmonds, Kim
Del Rosario, Lyra
Lingard, Karla
Mangwende, Mary
Holt, Lucy
Ahmod, Hamid
Korteweg, Justine
Foley, Tara
Barber, Taja
Emslie-Henry, Andrea
Caulfield-Lynch, Niamh
Byrne, Fiona
Deng, Daqi
Kjaer, Svend
Song, Ok-Ryul
Queval, Christophe
Kavanagh, Caitlin
Wall, Emma C
Carr, Edward J
Caidan, Simon
Gavrielides, Mike
MacRae, James I
Kelly, Gavin
Peat, Kema
Kelly, Denise
Murra, Aida
Kelly, Kayleigh
O'Flaherty, Molly
Shea, Robyn L
Gardner, Gail
Murray, Darren
Yousaf, Nadia
Jhanji, Shaman
Tatham, Kate
Cunningham, David
Van As, Nicholas
Young, Kate
Furness, Andrew J S
Pickering, Lisa
Beale, Rupert
Swanton, Charles
Gandhi, Sonia
Gamblin, Steve
Bauer, David L V
Kassiotis, George
Howell, Michael
Nicholson, Emma
Walker, Susanna
Larkin, James
Turajlic, Samra
author_sort Fendler, Annika
collection PubMed
description
format Online
Article
Text
id pubmed-8789238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-87892382022-01-26 Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer Fendler, Annika Shepherd, Scott T C Au, Lewis Wu, Mary Harvey, Ruth Schmitt, Andreas M Tippu, Zayd Shum, Benjamin Farag, Sheima Rogiers, Aljosja Carlyle, Eleanor Edmonds, Kim Del Rosario, Lyra Lingard, Karla Mangwende, Mary Holt, Lucy Ahmod, Hamid Korteweg, Justine Foley, Tara Barber, Taja Emslie-Henry, Andrea Caulfield-Lynch, Niamh Byrne, Fiona Deng, Daqi Kjaer, Svend Song, Ok-Ryul Queval, Christophe Kavanagh, Caitlin Wall, Emma C Carr, Edward J Caidan, Simon Gavrielides, Mike MacRae, James I Kelly, Gavin Peat, Kema Kelly, Denise Murra, Aida Kelly, Kayleigh O'Flaherty, Molly Shea, Robyn L Gardner, Gail Murray, Darren Yousaf, Nadia Jhanji, Shaman Tatham, Kate Cunningham, David Van As, Nicholas Young, Kate Furness, Andrew J S Pickering, Lisa Beale, Rupert Swanton, Charles Gandhi, Sonia Gamblin, Steve Bauer, David L V Kassiotis, George Howell, Michael Nicholson, Emma Walker, Susanna Larkin, James Turajlic, Samra Lancet Correspondence Elsevier Ltd. 2022 2022-01-25 /pmc/articles/PMC8789238/ /pubmed/35090602 http://dx.doi.org/10.1016/S0140-6736(22)00147-7 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Fendler, Annika
Shepherd, Scott T C
Au, Lewis
Wu, Mary
Harvey, Ruth
Schmitt, Andreas M
Tippu, Zayd
Shum, Benjamin
Farag, Sheima
Rogiers, Aljosja
Carlyle, Eleanor
Edmonds, Kim
Del Rosario, Lyra
Lingard, Karla
Mangwende, Mary
Holt, Lucy
Ahmod, Hamid
Korteweg, Justine
Foley, Tara
Barber, Taja
Emslie-Henry, Andrea
Caulfield-Lynch, Niamh
Byrne, Fiona
Deng, Daqi
Kjaer, Svend
Song, Ok-Ryul
Queval, Christophe
Kavanagh, Caitlin
Wall, Emma C
Carr, Edward J
Caidan, Simon
Gavrielides, Mike
MacRae, James I
Kelly, Gavin
Peat, Kema
Kelly, Denise
Murra, Aida
Kelly, Kayleigh
O'Flaherty, Molly
Shea, Robyn L
Gardner, Gail
Murray, Darren
Yousaf, Nadia
Jhanji, Shaman
Tatham, Kate
Cunningham, David
Van As, Nicholas
Young, Kate
Furness, Andrew J S
Pickering, Lisa
Beale, Rupert
Swanton, Charles
Gandhi, Sonia
Gamblin, Steve
Bauer, David L V
Kassiotis, George
Howell, Michael
Nicholson, Emma
Walker, Susanna
Larkin, James
Turajlic, Samra
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title_full Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title_fullStr Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title_full_unstemmed Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title_short Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
title_sort omicron neutralising antibodies after third covid-19 vaccine dose in patients with cancer
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789238/
https://www.ncbi.nlm.nih.gov/pubmed/35090602
http://dx.doi.org/10.1016/S0140-6736(22)00147-7
work_keys_str_mv AT fendlerannika omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT shepherdscotttc omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT aulewis omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT wumary omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT harveyruth omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT schmittandreasm omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT tippuzayd omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT shumbenjamin omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT faragsheima omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT rogiersaljosja omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT carlyleeleanor omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT edmondskim omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT delrosariolyra omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT lingardkarla omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT mangwendemary omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT holtlucy omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT ahmodhamid omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kortewegjustine omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT foleytara omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT barbertaja omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT emsliehenryandrea omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT caulfieldlynchniamh omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT byrnefiona omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT dengdaqi omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kjaersvend omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT songokryul omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT quevalchristophe omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kavanaghcaitlin omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT wallemmac omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT carredwardj omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT caidansimon omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT gavrielidesmike omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT macraejamesi omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kellygavin omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT peatkema omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kellydenise omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT murraaida omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kellykayleigh omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT oflahertymolly omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT shearobynl omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT gardnergail omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT murraydarren omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT yousafnadia omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT jhanjishaman omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT tathamkate omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT cunninghamdavid omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT vanasnicholas omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT youngkate omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT furnessandrewjs omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT pickeringlisa omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT bealerupert omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT swantoncharles omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT gandhisonia omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT gamblinsteve omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT bauerdavidlv omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT kassiotisgeorge omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT howellmichael omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT nicholsonemma omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT walkersusanna omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT larkinjames omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT turajlicsamra omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer
AT omicronneutralisingantibodiesafterthirdcovid19vaccinedoseinpatientswithcancer